Manufactured by Merck, Inc., NuvaRing® was approved by the FDA on October 3, 2001, and began distribution in 2002. In marketing NuvaRing®, Merck, Inc. represented that NuvaRing® was the first and only once-a-month vaginal birth control ring, but with the same effectiveness as daily birth control pills.
However, it appears that the manufacturers of NuvaRing® may have inadequately tested NuvaRing® and failed to discover increased safety risks and other side effects associated with its use. A recent study sponsored by the FDA in 2011 specifically addresses NuvaRing® side effects and finds that its users are at an increased risk of suffering a blood clot when compared to users of second generation low estrogen oral contraceptives.
The findings in FDA’s study of an increased risk of VTEs for NuvaRing® users has been confirmed in a new article published in the British Medical Journal, which found a doubling of the rate of serious blood clots among women using NuvaRing® compared to second generation oral contraceptives.
Burg Simpson anticipates that further studies will begin to emerge regarding the increased risks of NuvaRing® and etonogestrel.
Injuries and Side Effects Associated With NuvaRing®
- Deep vein thrombosis (DVT; blood clot in a deep vein)
- Pulmonary embolism (PE; blood clot in the lung)
- Heart attack
What is NuvaRing®?
NuvaRing® is a combination contraceptive vaginal ring that contains two active ingredients: etonogestrel and ethinyl estradiol. Etonogestrel is the active metabolite of desogestrel, which is classified as a third generation progestin. Studies concerning oral contraceptives that contain desogestrel and other third generation progestins report an increased risk of venous thromboembolism compared to second-generation products. In its product label, however, the manufacturer of NuvaRing® states that it is unknown whether NuvaRing® increases the risk of venous thromboembolism.
National Leaders in Contraceptive Litigation
Burg Simpson has a national reputation as a being a leader for plaintiffs and victims in personal injury litigation against large pharmaceutical companies.
If you or a loved one has used NuvaRing® and suffered from any of the NuvaRing® side effects or injuries listed above, please contact us today for a free consultation.
Disclaimer – The contents of the Burg Simpson.com website, including text, graphics, images, and other material contained herein (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Burg Simpson.com website!
If you think you may have a medical emergency, call your doctor or 911 immediately. We do not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site. Reliance on any information provided by Burg Simpson.com or Burg Simpson employees is solely at your own risk.